Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis [Phase 2]
A Phase 2 maintenance trial of the probiotic combination of Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis for Ulcerat…
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: Dose Escalation and Remission (DEAR) [Phase 4]
Phase 4 trial DEAR for Ulcerative Colitis has completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Vaccines and Dietary Oats in the Treatment of Ulcerative Colitis [Phase 2]
A Phase 2 trial evaluating vaccines and dietary oats for ulcerative colitis was terminated, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-04-20Clinical Trial Update: Dietetic Efficacy of Mare's Milk for Patients With Chronic Inflammatory Bowel Diseases [NA]
A clinical trial evaluated Mare's milk as a dietary treatment for chronic inflammatory bowel diseases (Ulcerative colitis and Crohn's diseas…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Managing Inflammatory Bowel Disease [NA]
This entry notes the completion of a University of Washington-sponsored clinical trial focused on managing inflammatory bowel disease, inclu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-04-08Clinical Trial Update: Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission [Phase 4]
Phase 4 clinical trial evaluating golimumab for induction and maintenance of clinical and endoscopic remission in steroid-dependent ulcerati…
-
CLINICAL_TRIALS safety_alert · 2015-04-07Clinical Trial Update: Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel Disease
This clinical trial update reviews the safety of anti-TNF monoclonal antibodies in inflammatory bowel disease, including ulcerative colitis …
-
CLINICAL_TRIALS research · 2015-04-03Clinical Trial Update: Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis [NA]
The study measured levels of Stat4 alpha and Stat4 beta isoforms in peripheral blood mononuclear cells from patients with Crohn's disease an…
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis [Phase 2]
A Phase 2 clinical trial evaluating VB-201 for Ulcerative Colitis has completed and reported its efficacy and safety evaluation.
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: Fecal Biotherapy for the Induction of Remission in Active Ulcerative Colitis [Phase 2]
Phase 2 clinical trial evaluating fecal biotherapy to induce remission in active ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181. [Phase 1]
This clinical trial update describes a Phase 1 study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of AMG 181. …
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating safety and efficacy of telotristat etiprate (LX1606) in acute, mild to moderate ulcerative colitis completed with r…
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis. [Phase 3]
Phase 3 trial comparing once-daily mesalazine 4 g to 4 g given in two divided doses for active ulcerative colitis has completed.
-
FDA label_change · 2015-02-25FDA Approved: SULFASALAZINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for sulfasalazine from Teva Pharmaceuticals USA, updating the product labeling.
-
CLINICAL_TRIALS research · 2015-02-18Clinical Trial Update: Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA
An observational study evaluating the management of ulcerative colitis with oral mesalamine (5-aminosalicylic acid) has been completed.
-
CLINICAL_TRIALS trial_result · 2015-02-05Clinical Trial Update: Comparison of Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative Colitis [Phase 2]
This update reports on a Phase 2 clinical trial comparing methotrexate to placebo for corticosteroid-dependent ulcerative colitis. The study…
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease
A long-term trial of scheduled infliximab therapy for inflammatory bowel disease has completed, evaluating its use in Crohn's disease and ul…
-
CLINICAL_TRIALS research · 2015-01-09Clinical Trial Update: Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease [Phase 2]
This update relates to a Phase 2 clinical trial evaluating standardized fecal microbiota transplantation for inflammatory bowel disease, inc…
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: Transplantation of Faeces in Ulcerative Colitis; Restoring Nature's Homeostasis [Phase 2]
Phase 2 clinical trial evaluating fecal microbiota transplantation for ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice
The document reports the completion of a clinical trial evaluating the use of anti-TNF therapy in Danish patients with inflammatory bowel di…
-
FDA approval · 2014-12-19FDA Approved: SIMPONI — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for SIMPONI (golimumab) submitted by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Post-Op Quality of Life After Colorectal Surgery
Completed clinical trial update evaluating post-operative quality of life after colorectal surgery across several colorectal conditions.
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Follow-Up Phone Calls After Colorectal Surgery
A completed clinical trial evaluating follow-up phone calls after colorectal surgery.
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: TP0502-B-Pharmaco-Scintigraphic-Study [Phase 1]
A Phase 1 pharmaco-scintigraphic study of TP0502-B for ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: TP0502-Pharmaco-Scintigraphic-Study and Amendment [Phase 1]
Tillotts Pharma AG reports completion of a Phase 1 pharmaco-scintigraphic study and amendment for TP0502 in Ulcerative Colitis.